IMU Biosciences Adopts Curiox's Pluto for Large-Scale UK Immune Profiling Initiative

Contributed by: GlobeNewswire

Tags

Biotechnology

More Like This

IMU Biosciences announces oversubscribed financing round, bringing its Series A to over $53M as it accelerates its work to decode the immune system with unprecedented resolution and scale, to transform how we understand, diagnose and treat disease

PR Newswire associated0

BioVaxys Acquires All Intellectual Property, Immunotherapeutics Platform Technology, and Clinical Stage Assets of the Former IMV Inc.

Biognosys Presents Major Innovations Across the Spectrum of Proteomics Research Applications at the HUPO World Congress

University of Manchester Techbio Spin-Out Secures £5 Million to Deploy Quantum Physics, AI Modelling, and Highly Automated Labs to Power Next Gen Enzyme Engineering

GRAPH: Scientific Idea Generation Performance Comparison - Scinapse AI vs. Google Gemini 2.5 Pro vs. Claude Opus 4 (Evaluation conducted by Pluto Labs)

Pluto Labs' 'Strategic Efficiency' AI Outperforms Google & Anthropic Models at a Fraction of the Cost

Endometrial immune Profiling and Precision Care Lead to Significantly Higher Live Birth Rates, MatriceLab Trial Shows

Bionoxx to Highlight Innovative Strategy for Addressing Immune-Related Diseases at 2024 BIO International Conference

Biognosys to Launch Metabolomics/Lipidomics Services for Multiomics Drug Discovery and Clinical Research